The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Upstream Bio Inc shares valued at $14,025,000 were purchased by Chimovits Erez on Oct 15 ’24. At $17.00 per share, Chimovits Erez acquired 825,000 shares. The insider’s holdings grew to 4,554,873 shares worth approximately $96.84 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, ORBIMED ADVISORS LLC purchased 825,000 shares, netting a total of over 14,025,000 in proceeds. Following the buying of shares at $17.00 each, the insider now holds 4,554,873 shares.
Before that, AI Upstream LLC had added 1,175,000 shares to its account. In a trade valued at $19,975,000, the 10% Owner bought Upstream Bio Inc shares for $17.00 each. Upon closing the transaction, the insider’s holdings increased to 1,175,000 shares, worth approximately $24.98 million.
As published in their initiating research note from William Blair on November 05, 2024, Upstream Bio Inc [UPB] has been an Outperform. Analysts at TD Cowen started covering the stock with ‘”a Buy”‘ outlook in a report released in early November. As of November 05, 2024, Piper Sandler has initiated its “an Overweight” rating for UPB. Earlier on November 05, 2024, JP Morgan initiated its rating. Their recommendation was “an Overweight” for UPB stock.
Analyzing UPB Stock Performance
During the last five days, there has been a surge of approximately 18.05%. Over the course of the year, Upstream Bio Inc shares have dropped approximately -3.36%. Nevertheless, trading volume fell to 0.18 million shares from 0.18 million shares the previous day.
Support And Resistance Levels for Upstream Bio Inc (UPB)
According to the 24-hour chart, there is a support level at 19.25, which, if violated, would cause prices to drop to 17.25. In the upper region, resistance lies at 22.45. The next price resistance is at 23.65. RSI (Relative Strength Index) is 45.46 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -2.94, which suggests the price will decrease in the coming days. Percent R is at 65.84%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
